WENDY SANTIAGO: Open Payments
NPI 1144863077 · BEAUFORT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,134 in 47 payments from 11 companies in 2025. Trend: 2023 $1,102 · 2024 $1,203 · 2025 $1,134
Food & beverage: $1,134
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $210 |
| Otsuka America Pharmaceutical, Inc. | 5 | $201 |
| Teva Pharmaceuticals USA, Inc. | 5 | $159 |
| Alkermes, Inc. | 9 | $152 |
| ABBVIE INC. | 10 | $144 |
| E.R. Squibb & Sons, L.L.C. | 3 | $78 |
| Janssen Pharmaceuticals, Inc | 3 | $74 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Lundbeck LLC | 1 | $24 |
Products named: HETLIOZ, ARISTADA, VRAYLAR, ABILIFY MAINTENA, COBENFY, UZEDY, INVEGA SUSTENNA, ABILIFY ASIMTUFII.
Industry payments across SC — which companies pay providers there.
